Couples at increased risk of transmitting a monogenic disease, such as cystic fibrosis, muscular dystrophies, or hereditary metabolic disorders.
PGT-M is an advanced preimplantation genetic testing procedure that enables the identification of mutations associated with monogenic diseases before the embryo is transferred into the uterus. Through this method, embryos that do not carry the familial mutation can be selected, reducing the risk of transmitting the disease to the child.
PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) is a genetic analysis performed within IVF treatments to detect specific mutations associated with hereditary conditions caused by a single gene. The procedure involves collecting a small number of cells from the embryo at the blastocyst stage without affecting its development.
The genetic sample is analyzed using advanced technologies such as next-generation sequencing to determine whether the embryo is affected, a carrier, or free of the familial mutation. This evaluation enables the selection of healthy embryos for transfer.
PGT-M is recommended for couples with a family history of monogenic diseases or for individuals who are identified carriers through preconception genetic testing.
Couples at increased risk of transmitting a monogenic disease, such as cystic fibrosis, muscular dystrophies, or hereditary metabolic disorders.
Individuals who are carriers of a genetic mutation identified through personal or family genetic testing.
Situations in which selecting embryos without the mutation is desired to ensure a pregnancy with minimal genetic risk.
Every treatment is built on a well-defined medical process, carefully structured and tailored to the individual needs of each case. The objective is for the patient to receive clear information, continuous support, and the assurance that every stage is explained in detail—from the initial consultation to the subsequent monitoring period. The entire journey is guided with professionalism, ensuring that medical decisions are made with full understanding.
Although procedures vary depending on each patient’s diagnosis, treatment always begins with a thorough evaluation of the individual situation and the establishment of a personalized strategy. This approach increases the real chances of success and ensures continuity of care throughout the entire journey toward becoming a parent.
Puteți lua legătura direct cu mine pentru clarificări, informații suplimentare sau programarea unei consultații.
Stabiliți o întâlnire medicală pentru evaluarea situației dumneavoastră și discutarea opțiunilor de tratament.
Stabilirea unui plan terapeutic personalizat, adaptat diagnosticului și nevoilor dumneavoastră medicale.
Fiecare pacient are un traseu unic în evaluarea și tratarea infertilității. Vă sprijin cu atenție și profesionalism în fiecare etapă.
Starting a treatment or medical procedure often raises questions regarding safety, effectiveness, and its impact on fertility. This section provides general explanations to help patients better understand the working steps, what the procedure involves, and what results to expect. The information is presented in an accessible manner to facilitate a clearer understanding of the medical process.
If additional questions arise or if the individual situation requires specific clarifications, a direct discussion with the physician can offer personalized guidance and recommendations tailored to each case. Proper guidance supports informed decision-making and ensures that treatment proceeds safely.
If you have questions related to monogenic disorders (PGT-M) or would like recommendations on evaluating and monitoring your newborn during the first days of life, you may request an individual consultation at any time. A thorough assessment helps determine the most suitable monitoring and support plan for your child.